These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17627500)

  • 1. HIV-1 integrase: from biology to chemotherapeutics.
    Zeinalipour-Loizidou E; Nicolaou C; Nicolaides A; Kostrikis LG
    Curr HIV Res; 2007 Jul; 5(4):365-88. PubMed ID: 17627500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing HIV integrase inhibitors--shooting the last arrow.
    Makhija MT
    Curr Med Chem; 2006; 13(20):2429-41. PubMed ID: 16918363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HIV-1 integrase with strand transfer inhibitors.
    Li Y; Xuan S; Feng Y; Yan A
    Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in diketo-containing inhibitors of HIV-1 integrase.
    Zhao G; Wang C; Liu C; Lou H
    Mini Rev Med Chem; 2007 Jul; 7(7):707-25. PubMed ID: 17627583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV integrase as a target for antiviral chemotherapy.
    Nair V
    Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV-1 integrase drugs: how far from the shelf?
    Pani A; Marongiu ME
    Curr Pharm Des; 2000 Mar; 6(5):569-84. PubMed ID: 10788597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents.
    Nair V
    Curr Pharm Des; 2003; 9(31):2553-65. PubMed ID: 14529542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C; Bailly F; Cotelle P
    Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral integrase inhibitors year 2000: update and perspectives.
    Pommier Y; Marchand C; Neamati N
    Antiviral Res; 2000 Sep; 47(3):139-48. PubMed ID: 10974366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors.
    Xu YW; Zhao GS; Shin CG; Zang HC; Lee CK; Lee YS
    Bioorg Med Chem; 2003 Aug; 11(17):3589-93. PubMed ID: 12901903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inhibitors of HIV-1 integration.
    Witvrouw M; Van Maele B; Vercammen J; Hantson A; Engelborghs Y; De Clercq E; Pannecouque C; Debyser Z
    Curr Drug Metab; 2004 Aug; 5(4):291-304. PubMed ID: 15320701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based inhibitor design targeting HIV-1 integrase.
    Chen IJ; Neamati N; MacKerell AD
    Curr Drug Targets Infect Disord; 2002 Sep; 2(3):217-34. PubMed ID: 12462126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
    Taktakishvili M; Neamati N; Pommier Y; Nair V
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1433-5. PubMed ID: 11378371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV integrase: a target for drug discovery.
    Lutzke RA; Plasterk RH
    Genes Funct; 1997 Dec; 1(5-6):289-307. PubMed ID: 17366700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.
    Sippel M; Sotriffer CA
    J Chem Inf Model; 2010 Apr; 50(4):604-14. PubMed ID: 20230013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-infectives: clinical progress of HIV-1 integrase inhibitors.
    Al-Mawsawi LQ; Al-Safi RI; Neamati N
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):213-25. PubMed ID: 18537517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.